Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Carolyn Owen — Length: 05:00 ALPINE Trial Demonstrates Superior Response of Second-Generation BTK Inhibitor in CLL/SLL Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10-13, 2022 — New Orleans, Louisiana ALPINE Head-to-head Trial, Second-generation BTK Inhibitor Shown to be More Effective and Safer in CLL Download 4 PowerPoint slides
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Dennis Kim — Length: 05:18 STAMP Inhibitor Broadens the Treatment Landscape in Chronic Myeloid Leukemia Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10-13, 2022 — New Orleans, Louisiana Novel Small Molecule Inhibitor Broadens the Treatment Landscape in Chronic Myeloid Leukemia Download 4 PowerPoint slides
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Laurie H. Sehn — Length: 05:00 New Data Shifts Risk-benefit of BTK Inhibitors in CLL/SLL Watch Presentation
rheumatology American College of Rheumatology (ACR) Convergence 2022: Expert Interview Dr. Tom Appleton — Length: 07:00 Head-to-head Trial Renews Emphasis on Radiographic Progression as a Therapeutic Goal in Axial Spondyloarthritis Watch Presentation
rheumatology American College of Rheumatology (ACR) Convergence 2022 November 10-14, 2022 — Philadelphia, Pennsylvania Biologics Attenuate Radiographic Progression over 2-Year Period in Patients with Axial Spondyloarthritis Download 4 PowerPoint slides
Cardiology American Heart Association (AHA) 2022 Scientific Sessions: Expert Interview Dr. Lawrence Leiter — Length: 05:10 Long-term Data Reaffirms the Benefits of siRNA Therapy on LDL-C Suppression Watch Presentation
Cardiology American Heart Association (AHA) 2022 Scientific Sessions November 5-7, 2022 — Chicago, Illinois Lipid-lowering Efficacy Sustained Over 4 Years with Twice-yearly Injections of a First-in-class Therapy Download 5 PowerPoint slides
neurology 27th International Annual Congress of the World Muscle Society (WMS): Expert Interview Dr. Laurent Servais — Length: 07:59 Modifying the Course of SMA: Real-world Outcomes from the RESTORE Registry Watch Presentation
neurology 27th International Hybrid Annual Congress of the World Muscle Society (WMS) October 11-15, 2022 — Halifax, Nova Scotia Gene Replacement Therapy Fosters Age-appropriate Development in Spinal Muscular Atrophy Download 4 PowerPoint slides
neurology 27th International Annual Congress of the World Muscle Society (WMS): Expert Interview Dr. Laurent Servais — Length: 05:42 Benefits of Gene Replacement Therapy on Bulbar Function Preservation in Patients with SMA Watch Presentation